Investors settled in for a largely quiet trading session on Tuesday. With a speech expected from Federal Reserve chair Jerome Powell on Wednesday, most market participants were content to wait and see what the central banker will say about the future path of monetary policy.
The latest PMCF study demonstrates that Boston Scientific's (BSX) ACURATE neo2 Aortic Valve System is expected to significantly improve patient outcomes.
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.